[Presentation of Japanese Materials] Strengthening Research and Development with Industry-Leading Computational Chemistry Tools

Schrödinger, Inc. will exhibit and present at the 145th Annual Meeting of the Pharmaceutical Society of Japan. Formulation research is one of the important processes in drug development, but in recent years, there has been a stronger demand for high efficiency and cost reduction. In this context, recent advancements in computers and molecular simulation technology have made it possible to predict physical properties, which was previously difficult to achieve in practice. In particular, our company is actively engaged in the development of software for formulation research as a leading company in molecular simulation software. 【Joint Symposium Date and Location】 March 27 (Thursday) 17:17 - 17:47 Venue: Room 4 (Fukuoka International Congress Center, 201 [2F]) Title: DX of Formulation Research Using Molecular Simulation and Machine Learning 【Exhibition Booth】 No.: 5F B-22 We look forward to your visit.

Schrödinger, Inc. will participate in the 3rd Annual Meeting of the Japanese Society for Antibody Research. Venue: Sendai International Center (Miyagi) 【Luncheon Seminar】 Date and Time: December 11 (Wed) 12:30 - 13:30 Title: Schrödinger's approach to physics-based antibody analysis and design Presenter: Shuu Ichihara (Schrödinger, Inc.) 【Booth No. 26】 We will introduce Schrödinger's drug discovery support platform and contract analysis services. - Latest docking simulation analysis - High-speed and high-precision binding free energy predictions - Multifunctional ligand-based analysis - Analysis using machine learning - Antibody structure modeling - Protein-protein interaction analysis - Discussion platform for managing, sharing, and analyzing simulation data and experimental data of compounds - Contract analysis services for each simulation